Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03674869
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
PEM![]() | 2-[P-[2-P-CHLOROBENZAMIDO)ETHYL]PHENOXY]- 2-METHYLPROPIONIC ACID | A,B | 1IWH | 0.71 | ![]() |
CHP![]() | 3-CHLORO-4-HYDROXYPHENYLGLYCINE | A | 1DSR | 0.7 | ![]() |
177![]() | 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]- PYRROLIDINE-3-CARBOXYLIC ACID 5- CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)- BENZYLAMIDE | A,B | 1TA6 | 0.71 | ![]() |
CMQ![]() | N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)- 2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]- L-LEUCINAMIDE | A,B,C,D,E,F, G,H,I,J,K,L, M,N | 2FZS | 0.7 | ![]() |
T76![]() | (6R,21AS)-17-CHLORO-6-CYCLOHEXYL- 2,3,6,7,10,11,19,20-OCTAHYDRO-1H,5H- PYRROLO[1,2-K][1,4,8,11,14]BENZOXATETRAAZA- CYCLOHEPTADECINE-5,8,12,21(9H,13H,21AH)- TETRONE | A,H | 1NT1 | 0.7 | ![]() |
NLT![]() | N-DODECANOYL-L-TYROSINE | A,B,C,D,E,F, G,H | 2G0B | 0.71 | ![]() |
ECA![]() | N,N',N''-[BENZENE-1,3,5-TRIYLTRIS(METHYLENE)]TRIS(2,3- DIHYDROXYBENZAMIDE) | A,B | 2CHU | 0.72 | ![]() |
CNT![]() | N-METHYL-META-CHLORO-TYROSINE | C,D | 1OKX | 0.72 | ![]() |
TYP![]() | CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR | A,B | 1W1Y | 0.73 | ![]() |
GAH![]() | N-{[(2S)-1-(N-{[4-({[AMINO(IMINO)METHYL]AMINO}METHYL)CYCLOHEXYL]CARBONYL}- 3-CYCLOHEXYL-L-ALANYL)AZETIDIN- 2-YL]CARBONYL}-L-TYROSYL-N~6~-[AMINO(IMINO)METHYL]- L-LYSINAMIDE | A,H | 1XM1 | 0.71 | ![]() |
R23![]() | METHYL-[4-(4-PIPERIDINE-1-YLMETHYL- PHENYL)-CYCLOHEXYL]-CARBAMINIC ACID- (4-CHLOROPHENYL)-ESTER | A,B,C | 1O79 | 0.73 | ![]() |
ARY![]() | ARYLOMYCIN A2 | A,B | 1T7D | 0.7 | ![]() |
F1I![]() | N-[1-(2,6-dimethoxybenzyl)piperidin- 4-yl]-4-sulfanylbutanamide | A | 2ZJI | 0.71 | ![]() |
843![]() | N-ACETYL-N-[1-(1,1'-BIPHENYL-4- YLMETHYL)-2-OXOAZEPAN-3-YL]-O-PHOSPHONOTYROSINAMIDE | A | 1O42 | 0.7 | ![]() |
TF3![]() | N-(2-AMINOETHYL)-2-{3-CHLORO-4- [(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE | A | 2BU7 | 0.71 | ![]() |
BFS![]() | N-[1-(4-BROMOPHENYL)ETHYL]-5-FLUORO SALICYLAMIDE | A | 1STD | 0.7 | ![]() |
BFS![]() | N-[1-(4-BROMOPHENYL)ETHYL]-5-FLUORO SALICYLAMIDE | A,B,C | 4STD | 0.7 | ![]() |
TI2![]() | (2-SULFANYL-3-PHENYLPROPANOYL)- PHE-TYR | A | 1QF0 | 0.71 | ![]() |
L47![]() | 3-[(5S)-1-ACETYL-3-(2-CHLOROPHENYL)- 4,5-DIHYDRO-1H-PYRAZOL-5-YL]PHENOL | A,B | 1YRS | 0.75 | ![]() |
OI1![]() | 3-(4-HYDROXYBENZYL)-2-[1-({[2-(4- HYDROXYPHENYL)ETHYL]AMINO}CARBONYL)BUTYL]- 4-OXO-3,6,11,11A-TETRAHYDRO-4H- PYRAZINO[1,2-B]ISOQUINOLIN-2-IUM- 1-OLATE | A,B | 1Q9D | 0.7 | ![]() |
3QC![]() | (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8- TETRAMETHYL-3,4-DIHYDROISOQUINOLINE- 2(1H)-CARBOXAMIDE | A,B | 2FME | 0.73 | ![]() |